Varian
Varian Medical Systems, commonly referred to as Varian, is a leading player in the healthcare technology sector, headquartered in the United States. Founded in 1948, the company has established itself as a pioneer in radiation oncology, providing innovative solutions for cancer treatment. With a strong presence in North America, Europe, and Asia, Varian focuses on advanced medical devices and software that enhance cancer care. The company’s core offerings include radiotherapy systems, software for treatment planning, and comprehensive patient management solutions. Varian's commitment to precision and efficiency sets its products apart in the competitive landscape. Recognised for its contributions to the field, Varian has achieved significant milestones, including the development of cutting-edge technologies that improve patient outcomes. As a trusted name in oncology, Varian continues to shape the future of cancer treatment globally.
DitchCarbon Score
How does Varian's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Varian's score of 39 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Varian's reported carbon emissions
In 2018, Varian Medical Systems, Inc. reported total carbon emissions of approximately 606,554,000 kg CO2e, with Scope 1 emissions at about 21,486,000 kg CO2e, Scope 2 emissions at approximately 9,029,000 kg CO2e, and Scope 3 emissions reaching about 576,039,000 kg CO2e. The Scope 3 emissions included significant contributions from purchased goods and services (approximately 293,779,890 kg CO2e) and the use of sold products (about 120,968,190 kg CO2e). Varian has set ambitious reduction targets, aiming to decrease its carbon footprint by a minimum of 25% from a 2010 baseline by 2020 for both Scope 1 and Scope 2 emissions. Additionally, in 2019, the company reported a 40% reduction in greenhouse gas emissions, alongside a 55% decrease in energy expenses, although these figures are not explicitly broken down by scope. The emissions data is cascaded from Varian Medical Systems, Inc., which is a current subsidiary of Siemens Healthineers AG. This relationship may influence Varian's climate commitments and reporting practices. As of the latest data, Varian has not disclosed specific targets under the Science Based Targets initiative (SBTi).
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | |
|---|---|---|
| Scope 1 | 10,811,000 | 00,000,000 |
| Scope 2 | 1,887,137,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Varian is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
